| abstract |
Methods and compositions for the treatment of the heart are provided. A composition comprising a digested, decellularized extracellular matrix derived from heart tissue, the extracellular matrix having a pore size of about 30-40 microns, wherein the composition comprises: The composition can be injected through a catheter with an inner diameter of 25 G or less, wherein the extracellular matrix comprises glycosaminoglycan at a concentration of about 60 to 120 μg per mL of extracellular matrix object. [Selection] Figure 1 |